Single-Cell Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Single-Cell Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global single-cell analysis market, valued at US$ 4.9 Billion in 2024, is poised for remarkable growth from 2024 to 2031. This impressive expansion is driven by a convergence of factors that are reshaping the landscape of single-cell analysis.

Uncovering the Keys to Human Health

One of the primary catalysts behind this growth is the increasing focus on advancing human health. Researchers worldwide are harnessing the power of single-cell analysis to study immune responses and long-term effects of infections, with a particular emphasis on COVID-19. For example, in March 2021, a groundbreaking single-cell meta-analysis involving 1,320,896 cells from 228 humans was conducted to understand the entry genes of SARS-CoV-2 across demographics.

Additionally, the demand for single-cell analysis is surging in various omics research activities, such as genomics, proteomics, transcriptomics, and metabolomics. These endeavors enable the analysis of extensive datasets, uncovering genetic foundations crucial for disease diagnosis and drug discovery. Technological advancements have led to high throughput assays, efficient cell sorting, sequencing, microfluidics, single-cell amplification, and advanced software tools, all contributing to market growth.

Fueling Innovative Research

Innovative research initiatives and increased funding have spurred the development of high-throughput equipment within the market. These tools now offer features like automation, high sensitivity, and accuracy, facilitating the analysis of rare samples. For instance, in March 2022, Deepcell Inc., a U.S.-based company, secured $73 million in funding to accelerate its AI-powered single-cell analysis platform.

Despite these promising prospects, market penetration faces challenges due to the high cost of instruments and consumables. Ongoing maintenance costs and other associated expenses can create limitations for clinical and research applications with budget constraints.

Constraints on Market Growth

The high cost of research in single-cell biology, necessary to maintain high-quality standards and comply with regulatory guidelines, poses a significant restraint on market growth. Research and academic laboratories often struggle to afford expensive instruments due to budget limitations, compounded by maintenance costs and indirect expenses.

Regional Insights
• North America: Dominated the global market in 2023 with a revenue share exceeding 35%. This dominance can be attributed to government funding programs, increasing awareness of personal healthcare, rapid adoption of innovative analytical tools, and a pool of trained personnel.
• Asia Pacific: Expected to exhibit the fastest CAGR over the forecast period. Growth in the medical industry, developing healthcare systems, and an aging population are driving the demand for cutting-edge diagnostic tools in the region.

Country-wise Insights

Why Suppliers of Single-Cell Analysis are Investing in the U.S.?

The United States stands out as a highly favorable market for single-cell analysis. It boasts advanced healthcare infrastructure, extensive research activity, and support from the government, making it an attractive hub for suppliers and manufacturers. The high incidence of chronic diseases like cancer further drives market growth, along with the presence of major players and new product launches.

China's Evolving Market

China's single-cell analysis market is set to evolve, fueled by increasing healthcare expenditure and favorable government policies that promote healthcare infrastructure development. The COVID-19 pandemic has also heightened the focus on healthcare in the region. Pharmaceutical and biotechnology companies in China are significant end users, further contributing to market growth.

Competitive Analysis

Key players in the single-cell analysis market are actively advancing research and expediting the development of new products to gain a competitive edge. These companies are expanding their production capacities to meet the growing demand and are forming partnerships and collaborations to strengthen their presence in the market.

Key Companies Profiled
• Thermo Fisher Scientific Inc.
• Qiagen N.V
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• Merck KGaA
• Becton, Dickinson & Company
• Fluidigm Corporation
• 10x Genomics Inc.
• BGI
• Novogene Corporation

Key Segments in Single-Cell Analysis Industry Research

By Consumables
• Consumables
Reagents
Assay Kits
• Instruments
Manual Instruments

 Microscopes

 Hemocytometers
Automated Instruments

 Flow Cytometers

 Next Generation Sequencing

 PCR Systems

 High-content Screening System

 Cell Microarrays

 Automated Cell Counters

By Application Type
• Cancer
• Immunology
• Neurology
• Stem Cell
• Non-invasive Prenatal Diagnosis
• In-vitro Fertilization
• Others

By Workflow
• Single Cell Isolation & Library Preparation
• Downstream Analysis
• Data Analysis

By End User
• Academic & Research Laboratories
• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Laboratories
• Others

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.